The Role of Antioxidants in Vascular Protection
Free radicals and lipid peroxidation (LPO) are major triggers of the atherosclerotic process. Antioxidants suppress these reactions by reducing radicals to stable forms.
Based on their mechanism of action, they are classified into:
- Direct: bind and inactivate free radicals independently.
- Indirect: stimulate the body's own protective antioxidant systems.
Natural protectors include ascorbic acid (vitamin C), vitamins A and D, tocopherols (vitamin E), and carotenoids. Statins also exhibit an important pleiotropic (additional) antioxidant effect.
Key Antioxidant Drugs
Several specific agents are used in the combination therapy of atherosclerosis:
- Probucol. A lipophilic bisphenol structurally similar to vitamin E. It works in two directions: it inhibits LPO (preventing the formation of "foam" cells in the intima) and lowers LDL levels by activating their hepatic uptake. Main drawback: it concurrently decreases the level of beneficial antiatherogenic HDLs. The drug is very poorly absorbed (2–6%), deposits in adipose tissue, and its peak effect is achieved only after 1–3 months of regular intake.
- Eiconol. A marine hydrobiont complex containing 20% omega-3 triglycerides (eicosapentaenoic and docosahexaenoic acids), as well as vitamins A, D, and E. It normalizes lipoprotein structure, dilates blood vessels, lowers blood pressure, and combats arrhythmias.
- Tykveol. A herbal preparation made from pumpkin seed oil (Cucurbita pepo). Contains phospholipids, B, C, and PP vitamins, tocopherols, and flavonoids. In addition to normalizing the lipid profile, it acts as a hepatoprotector, choleretic, and anti-inflammatory agent, and is used in urology to inhibit prostate cell proliferation.
Mechanism of Antiplatelet Action of Omega-3
The efficacy of polyunsaturated fatty acids (PUFAs) is related to their interference with arachidonic acid metabolism.
- Eicosapentaenoic acid competes with arachidonic acid in eicosanoid synthesis pathways.
- As a result, prostanoids are formed with three double bonds instead of two.
- Thromboxane $A_3$ is synthesized, which induces platelet aggregation significantly weaker than the arachidonic acid derivative, thromboxane $A_2$.
- Against this background, the activity of prostacyclins (natural antiplatelet agents) increases.
Conclusion: the biochemical balance shifts toward substances that prevent thrombus formation.
Angioprotectors: Targets and Application
Angioprotectors act directly on the blood vessel wall: they normalize metabolism within it, reduce permeability, and improve microcirculation. They are prescribed for vascular lesions of any caliber:
- Arteries. In atherosclerosis, plaques form in the inner layer. Angioprotectors reduce the permeability of the vascular wall, preventing atherogenic lipoproteins from penetrating inside. They are used strictly in combination with lipid-lowering and antithrombotic medications.
- Veins. In varicose veins and thrombophlebitis, these drugs relieve edema and reduce wall permeability. They are used in combination with venotonics, NSAIDs, and anticoagulants.
- Capillaries. They protect small vessels during acute infections (e.g., capillarotoxicosis in influenza) and protect against chronic diabetic angiopathies (specifically, retinal vascular damage in insulin-dependent diabetes).
Briefly: answers to topical questions
Which drugs besides vitamins exhibit a pleiotropic antioxidant effect?
In addition to vitamins, a pleiotropic antioxidant effect is exhibited by:
- Statins — their antioxidant action is an important pleiotropic effect.
- Nebivolol — exerts an antioxidant effect.
- S-adenosylmethionine (ademetionine) — increases glutathione concentration, which is associated with an antioxidant effect.
- Drugs described in the source — stimulate the synthesis of endogenous α-tocopherol and increase the activity of catalase, glutathione peroxidase, and superoxide dismutase.
To quickly recall the pharmacodynamics of Tykveol, use the acronym AGFD: Antiatherosclerotic, Hepatoprotective, Choleretic, Anti-inflammatory action.
Class and exam questions
Why is Probucol prescribed only when other lipid-lowering agents are ineffective?
Despite its potent antioxidant effect, the drug has a severe side effect — it lowers the level of antiatherogenic high-density lipoproteins (HDLs), which are essential for vascular protection.
How long does the effect of Probucol persist after discontinuation?
The drug has high lipophilicity and is deposited in adipose tissue. Its aftereffect persists for more than 20 days, and its half-life exceeds one month.
What is the difference between thromboxane A2 and A3?
Thromboxane A2 is synthesized from arachidonic acid and causes strong platelet aggregation. Thromboxane A3 is formed from omega-3 acids (eicosapentaenoic) and has a significantly lower proaggregatory effect.
Which layer of the artery do angioprotectors affect in atherosclerosis?
The main target is the intima (inner layer). The drugs reduce its permeability, preventing the infiltration of atherogenic lipoproteins and the formation of plaques.
What else to study on this topic
- Receptor-independent endocytosis of lipoproteins by hepatocytes
- Arachidonic acid metabolic cascade and eicosanoid synthesis
- Pathogenesis of "foam" cell formation in the vascular intima
- Pleiotropic effects of statins in the therapy of atherosclerosis
- Mechanisms of development of diabetic microangiopathies
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Antioxidants and Angioprotectors in Atherosclerosis" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Drugs used in atherosclerosis"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.